Release Date: 10/08/09 14:40 Summary: Response to an ASX Appendix 4C Query Price Sensitive: Yes Download Document 278.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%